It's an appeal. It's a prior authorization, It's wrapped in with the clinical trial. No, it's back to a prior authorization. It's Super-Conflated.
After hours on hold and multiple lateral passes yesterday, I thought that when I finally got a phone number and a reference number from a case manager for my local oncologist to use with clear instructions of what he needed to do, the path was clear to a yes or no.
Boy, was I naive. His nurse got the same polite run around that I did today.
But everyone (even me), is very sweet and tries to be oh so helpful.
Remember all I am trying for is authorization for the relatively cheap mandatory consult to assess whether I am a candidate for the trial, not for the pricey trial itself. I understand quite sensibly that once it is ascertained that I indeed qualify, OSU will then apply for the trial coverage, and that is the real critical action. I am quite confident that will work out. And I am very confident that I will be in the trial by February.
I suspect, again probably naively, that the authorization for the trial itself is a more traveled route and an easier path to navigate.
This is just a fun and informative diversion in learning how the other big blue (not IBM but Blue Shield or BS) works.
The trial is the goal. I can pay for the consult, but not the trial. This is the practice run. I am keeping detailed records. I am hoping that I don't need them.
I am keeping my eyes on that prize. For a chance for real durable disease control. The excitement of a healthy and lengthy old age, a new drug that offers a true truce with my leukemia: these joyful possibilities almost get lost in these side battles.
2 Comments:
I think you should lobby Dr. Farooqui at NIH to amend his protocol so that people like you could be entered into their PCI study!
Good Luck
Thank you very much for keep this information. thanks this is good blog.
Hastings Claims Number
Post a Comment
Subscribe to Post Comments [Atom]
<< Home